JDRF Center of Excellence
in Northern California

This Center is a cure accelerator and a high impact partnership combining the scientific expertise of Stanford University and the University of California, San Francisco (UCSF) within the collaborative structure and support that are hallmarks of JDRF. Investigators at the Center will seek to better understand and target the interactions between the immune system and the beta cell, in an effort to deliver first-generation, stem cell-based cures for type 1 diabetes (T1D).

These world-class researchers will:

  • Discover and explain how immune cells interact with islets and beta cells in T1D
  • Generate islets and immune cells from stem cells as the basis for next-generation cell therapies
  • Develop an islet transplant protocol that will induce tolerance and not require immunosuppression

Research Team

Aaron J. Kowalski, Ph.D., JDRF

Bio

Esther Latres, Ph.D.,JDRF

Bio

Qizhi Tang, Ph.D., UCSF

Bio

Seung Kim, M.D., Ph.D., Stanford University

Bio

Mark Anderson, M.D., Ph.D., UCSF

Bio

Audrey Parent, Ph.D., UCSF

Bio

Kyle Loh, Ph.D., Stanford University

Bio

Alexander Marson, M.D., Ph.D., UCSF

Bio

Everett Meyer, M.D., Ph.D., Stanford University

Bio

Judith Shizuru, M.D., Stanford University

Bio

Julie Sneddon, Ph.D., UCSF

Bio

Linda Vo, Ph.D., UCSF

Bio

Jimmie Ye, Ph.D., UCSF

Bio

News & Blogs

  • JDRF 2023 NorCal Annual Meeting Research Discussion

    Understanding Autoimmunity and Harnessing the Power of Stem Cells for T1D Cures

    Watch video
    Test Image

  • June 2022 Progress Report

    Read the latest Report from these labs

    Download
    Test Image

  • JDRF Launches Northern California Center of Excellence To Accelerate Breakthroughs To Cure T1D

    September 04, 2019

    Read More
    Test Image

  • Fall 2020 Progress Report

    Read the latest Report from these labs

    Download
    Test Image

  • Spring 2020 Progress Report

    Read the latest Report from these labs

    Download
    Test Image

Support our Work

Contact us to help us advance this critical work in curing T1D and improving lives.

Kevin O’Scanlon
Associate National Director, Leadership Giving
JDRF
koscanlon@jdrf.org